I think part of the problem right now is lack of consistent daily volume. Further news might change that and with more volume should come more market interest. That can have a positive feedback on itself.
Canacord's research note target released earlier this month of $5.60 is an attractive near term target offering 64% gains from here.
Ann: $250K Convertible Note Drawdown to Fund Expansion, page-87
Add SPA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.02M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.2¢ | 2.2¢ | $19.06K | 866.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 2617267 | 2.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.3¢ | 2119009 | 3 |
View Market Depth
| Last trade - 12.26pm 27/09/2024 (20 minute delay) ? |
| SPA (ASX) Chart |